GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹318 Cr | ₹241 Cr | ₹187 Cr | ₹137 Cr | ₹98 Cr |
What is the latest Total Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹318 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹187 Cr |
| Mar2022 | ₹137 Cr |
| Mar2021 | ₹98 Cr |
How is Total Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹318 Cr | 31.87 | |
| Mar2024 | ₹241 Cr | 29.13 | |
| Mar2023 | ₹187 Cr | 36.30 | |
| Mar2022 | ₹137 Cr | 39.37 | |
| Mar2021 | ₹98 Cr | - | |
Compare Total Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,234.6 Cr | -4% | -11.1% | 37.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -4% |
-11.1% |
37.2% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses